Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

UPDATE: GlaxoSmithKline CEO Bonus Hit By China Probe, But Total Pay Still Jumps

3rd Mar 2014 16:01

LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although his total pay for the year still rose 63% as the company got six products approved and five additional regulatory filings comp Read More

GlaxoSmithKline CEO Bonus Hit By China Probe, But Total Pay Still Jumps

3rd Mar 2014 15:14

LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although Witty's total pay for the year still rose 63% as the company saw six products approved and five additional regulatory filings Read More

Glaxo Files New Drug Application For Promacta

28th Feb 2014 16:08

LONDON (Alliance News) - GlaxoSmithKline said Friday that it had submitted a new drug application to the US Food and Drug Administration for its severe aplastic anaemia treatment Promacta. The treatment is used for patients with the condition who have had an insufficient response to immunos Read More

DIRECTOR DEALINGS: Glaxo Executives Sell Shares, ADS For Tax Purposes

26th Feb 2014 17:32

LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of executives sold shares for tax purposes in the health company at a price of GBP16.73 per share Monday.<br /><br />Details are as follows.<br /><br /> <table class="af" cellspacing="0" cellpadding="0"><tbody><tr><td class Read More

DIRECTOR DEALINGS: Glaxo Executives Have ADSs Withheld For Tax

26th Feb 2014 14:24

LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said Executive Director Moncef Slaoui, General Counsel Dan Troy and Diedre Connelly, a divisional president, had American Depositary Shares withheld for tax purposes at a price of USD55.69 per ADS as part of the company share plan Monday.< Read More

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADS

25th Feb 2014 12:50

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives including Roger Connor a divisional president and Philip Thomson, a divisional senior vice president acquired shares while General Counsel James Ford and Executive Director Moncef Slaoui acquired American Depositar Read More

REPEAT: MARKET COMMENT: FTSE 100 Closes Up For Sixth Day, Third Week In A Row

21st Feb 2014 17:14

LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More

MARKET COMMENT: FTSE 100 Closes Up For Sixth Day, Third Week In A Row

21st Feb 2014 17:12

LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More

DIRECTOR DEALINGS: GlaxoSmithKline Executives Allocated ADSs

21st Feb 2014 16:58

LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that the a group of executives had their number of American Depositary Shares increased following a re-evaluation of the cash element of the notional investment held within the company's 401K plan. The ADSs were issued at USD56.22 each.< Read More

UK MIDDAY BRIEFING: FTSE 100 Heads For Sixth Daily Gain

21st Feb 2014 13:53

LONDON (Alliance News) - The FTSE 100 looks set to post its sixth consecutive daily rise Friday, as it nears its 2014 high amid a continuing rally in stock markets around the world, largely driven by the recovery of the world's largest economy.<br /><br />The focus in London Friday has been on Read More

UK WINNERS & LOSERS: IP Group, Millennium & Copthorne Lead FTSE 350 Risers

21st Feb 2014 11:57

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS Royal Bank of Scotland Group, up 2.4%. The bank is preparing a dramatic retrenchment that would see it become a much smalle Read More

REPEAT: TOP NEWS: Glaxo Buoyed As Drug Gets Recommended For Approval

21st Feb 2014 11:45

LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br />COMPANIES<br />----------<br /><strong>Royal Dutch Shell</strong> has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vito Read More

TOP NEWS: Glaxo Buoyed As Drug Gets Recommended For Approval

21st Feb 2014 11:40

LONDON (Alliance News) - The following is a summary of top news stories xxxxday.<br />----------<br />COMPANIES<br />----------<br /><strong>Royal Dutch Shell</strong> has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vit Read More

MARKET COMMENT: UK Stocks Trade Higher Despite Retail Sales Miss

21st Feb 2014 10:47

LONDON (Alliance News) - The FTSE 100 is on track to post its sixth consecutive daily rise Friday, as weaker-than-expected UK retail sales and public finances data failed to dent the recent market positivity. By mid-morning, the FTSE 100 is up 0.4% at 6,836.91, just over 30 points shy of it Read More

UK BROKER RATINGS: JPMorgan Raises View On Home Building Sector

21st Feb 2014 10:17

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />UBS RAISES VODAFONE PRICE TARGET TO 275 (260) PENCE - 'BUY' <br />----------<br />UBS CUTS SMITHS GROUP TO 'SELL' ('NEUTRAL') - Read More

UK MORNING BRIEFING: RBS, Glaxo Among The Early Risers

21st Feb 2014 08:18

LONDON (Alliance News) - Royal Bank Of Scotland Group is one of the top gainers early Friday on a report that it will shrink dramatically, while GlaxoSmithKline is off to a good start after one of its new drugs was recommended for approval in Europe.<br /><br />The London equity markets are hi Read More

Glaxo's Incruse Recommended For European Marketing Authorisation

21st Feb 2014 07:31

LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the dr Read More

Glaxo's Anoro For Treatment Of COPD Recommended For Marketing Authorisation

20th Feb 2014 12:48

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its treatment for chronic obstructive pulmonary disease Anoro had been recommended for marketing authorisation from the European Medicines Agency's committee for Medical Products for Human Use. Glaxo expects a final decision on Read More

MARKET COMMENT: UK Stocks Lose Momentum Ahead Of FOMC Minutes

19th Feb 2014 16:53

LONDON (Alliance News) - UK stocks have struggled to get off the ground Wednesday, closing broadly unchanged despite some impressive individual stock performances. The FTSE 100 initially opened higher, continuing a rally that has seen the index retrace most of January's losses. However, after bre Read More

UK Dividends Calendar - Week Ahead

19th Feb 2014 06:16

Read More

FTSE 100 Latest
Value10,436.29
Change71.50